Elicio Therapeutics (ELTX) Revenue (2020 - 2022)
Elicio Therapeutics' (ELTX) quarterly Revenue came in at $653000.0 in Q2 2022, up 20.93% YoY from $540000.0 in Q2 2021, and down 60.38% on a QoQ basis from $1.6 million in Q1 2022.
Elicio Therapeutics (ELTX) Revenue (2020 - 2022) Analysis & Trends
Elicio Therapeutics (ELTX) has 3 years of Revenue data on file, last reported at $653000.0 in Q2 2022.
- Quarterly Revenue rose 20.93% year-over-year to $653000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $653000.0 (down 97.79% YoY) and the FY2022 annual result came in at $2.3 million, down 91.87% from the prior year.
- Revenue eased to $653000.0 in Q2 2022, from $1.6 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $25.9 million in Q4 2021 to a low of $371000.0 in Q1 2021.
- A 3-year average of $3.6 million and a median of $729000.0 in 2020 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 5551.63% in 2021, down 25.93% in 2021.
- Tracing ELTX's Revenue over 3 years: stood at $459000.0 in 2020, then surged by 5551.63% to $25.9 million in 2021, then tumbled by 97.48% to $653000.0 in 2022.
- The last three Revenue figures came in at $653000.0 (Q2 2022), $1.6 million (Q1 2022), and $25.9 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 653,000.00 |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 25.94 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 540,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Dec 31, 2020 | 459,000.00 |
| Sep 30, 2020 | 827,000.00 |
| Jun 30, 2020 | 729,000.00 |